March 23, 2025 - 10:21
Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) have taken a significant step by sending a letter to the U.S. Food and Drug Administration (FDA). This letter, supported by over 20 prominent organizations and providers from various sectors of healthcare, emphasizes the urgent need for the FDA to implement and enforce federal regulations concerning compounding practices.
The call to action comes in the wake of recent shortages of GLP-1 medications, which are crucial for the treatment of obesity and related conditions. These shortages have raised serious concerns about patient access to essential therapies. The coalition argues that without stricter oversight and regulation of compounded medications, patients may face continued disruptions in their treatment options.
Healthcare leaders are advocating for a timely response from the FDA to ensure that patients receive the medications they need without interruption, highlighting the importance of regulatory frameworks in safeguarding public health.
July 1, 2025 - 04:06
Major Healthcare Fraud Bust in Indiana Involves 13 ArrestsThirteen residents from Indiana have been charged in a sweeping healthcare fraud investigation that officials are labeling as the largest of its kind in the history of the U.S. Department of...
June 30, 2025 - 14:13
Addressing Chronic School Absenteeism as a Public Health ConcernChronic absenteeism in schools is frequently the initial indicator of underlying issues affecting a child`s life. It serves as a crucial warning signal that should not be overlooked. Derwin L. Webb...
June 29, 2025 - 21:31
The Deteriorating Landscape of Transgender Health CareAs the “Big Beautiful Bill” faces uncertainty, the future of federal funding for gender-affirming care remains precarious. This instability has significant implications for transgender...
June 29, 2025 - 02:32
Embracing Gratitude: A Daily Routine for Longevity`For me, the first thing is to wake up every morning and just say how grateful you are to be there,` shares Jeffrey Bland, a pioneer in the field of functional medicine. At 79 years old, Bland...